MENU
+Compare
BSPK
Stock ticker: OTC
AS OF
Jan 17 closing price
Price
$0.08
Change
+$0.01 (+14.29%)
Capitalization
1.53M

BSPK Bespoke Extracts, Inc. Forecast, Technical & Fundamental Analysis

BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BSPK with price predictions
Jan 08, 2025

BSPK's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for BSPK moved out of overbought territory on January 03, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 instances where the indicator moved out of the overbought zone. In of the 20 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

BSPK moved below its 50-day moving average on January 08, 2025 date and that indicates a change from an upward trend to a downward trend.

BSPK broke above its upper Bollinger Band on January 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BSPK entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 02, 2025. You may want to consider a long position or call options on BSPK as a result. In of 149 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BSPK just turned positive on December 24, 2024. Looking at past instances where BSPK's MACD turned positive, the stock continued to rise in of 68 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BSPK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (256.410) is normal, around the industry mean (58.527). P/E Ratio (0.000) is within average values for comparable stocks, (90.460). BSPK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (26.247) is also within normal values, averaging (19.547).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BSPK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
2590 Walnut Street
Phone
+1 855 633-3738
Employees
2
Web
https://bespokeextracts.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGRTX15.420.12
+0.78%
Principal SmallCap Growth I Instl
GAFSX16.200.12
+0.75%
Gabelli Global Financial Services AAA
NMUEX10.370.07
+0.68%
Neuberger Berman Multi-Cap Opp E
JCVCX23.780.15
+0.63%
JHancock Classic Value C
WFMIX48.750.18
+0.37%
Allspring Special Mid Cap Value Inst

BSPK and Stocks

Correlation & Price change

A.I.dvisor tells us that BSPK and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
+23.82%
AVCNF - BSPK
9%
Poorly correlated
-8.22%
CHSYF - BSPK
9%
Poorly correlated
N/A
CAIHF - BSPK
4%
Poorly correlated
N/A
BOIRF - BSPK
4%
Poorly correlated
N/A
ARSUF - BSPK
2%
Poorly correlated
N/A
More

Groups containing BSPK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
+23.82%
Pharmaceuticals
category (309 stocks)
2%
Poorly correlated
+0.20%
Pharmaceuticals: Other
category (223 stocks)
1%
Poorly correlated
+0.11%